Is Annovis Bio, Inc. (ANVS) a Buy, Sell, or Hold?
NYSE : ANVS
Annovis Bio, Inc.
$1.74 USD
$0 (0.0%)
- Volume
- 619.48K
- Average Volume
- 1.11M
- Market Capitalization
- $34.23M
- P/E Ratio
- -1.01
- Dividend Yield
- 0.00%
- Price Target
- $26.00
- Year High
- $5.50
- Year Low
- $1.54
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.27
Analyst Consensus Summary
Consensus Rating
Strong Sell
8 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-93.3%
vs Current Price
Price Target
$26.00
Average TargetPrice Target Range
Lowest Target
$21.00
-91.7% DOWNSIDE
Average Target
$26.00
Median Estimate
Highest Target
$30.00
-94.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 6 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Raghuram Selvaraju | $30 | $8.82 | 2024-10-16 02:56 AM | 240.1% |
| EF Hutton | Jason Kolbert | $21 | $7.87 | 2024-08-13 03:05 AM | 166.8% |
| Canaccord Genuity | Sumant Kulkarni | $26 | $7.28 | 2024-04-30 03:34 AM | 257.1% |